Pharmacogenomics is an exciting and rapidly growing field that has the potential to revolutionize how we approach drug development and patient care. By understanding how genetic variations influence drug response, it is possible to develop more effective and personalized drug therapies, reducing the risk of adverse reactions and improving treatment outcomes. While there are still many challenges to be addressed in the field of pharmacogenomics.
Another example of Pharmacogenomics in clinical practice is the use of the drug cetuximab, which is used to treat certain types of cancer. Cetuximab works by blocking a protein called epidermal growth factor receptor (EGFR), which is involved in cancer cell growth and survival. However, some patients do not respond well to cetuximab, due to a genetic variation that results in overexpression of another protein called KRAS. Pharmacogenomic testing can help to identify patients who are likely to respond well to cetuximab, allowing for more effective and personalized treatment.
Discover More- https://cmiblogdailydose.blogspot.com/2023/04/pharmacogenomics-can-be-used-for.html
